In
the current study, we synthesised a novel series of
3-Chloro-1-phenyl-4-(pyridine-4yl-)azetidin-2-one derivatives using Schiff base
as an intermediary in the quest for prospective Tuberculosis treatments. The
resulting Schiff base is then eliminated, resulting in named Azetidinone
derivatives. Nucleophilic addition followed by elimination is the mechanism
involved in the production of Schiff base. The newly produced Schiff base is
then cyclized to produce novel Azetedinone derivatives. The named compounds
were physically examined and structurally investigated using spectroscopic
methods (IR, 1H-NMR, MASS). The chemicals Azt-1 to Azt-6 were tested for
anti-tubercular activity in vitro. The Micro plate Alamar Blue Assay (MABA)
method was used to test anti-tubercular activity in vitro. Azt-1(H), Azt-2(Cl),
Azt-5 (O-OH), and Azt-6 (P-OH) were the most active compounds in the series
compared to standards. The presence of electron withdrawing group -Cl, (Azt-2)
and electron donating substituents -OH at ortho and para positions in the
phenyl ring of (Azt-5) and (Azt-6) respectively could explain the potent anti
tubercular activity.
Author (S) Details
N. Pramod
Department of
Pharmaceutical Chemistry, A.G.M College of Pharmacy, Varur-581207, Hubli,
Karnataka, India.
C. Bharath Kumar
Department of Pharmaceutical Chemistry, Annamacharya College of Pharmacy,
Rajampet-516126, Kadapa, Andhra Pradesh, India.
P. Sri Lekha
Department of Pharmaceutical Chemistry, Institute of Pharmaceutical
Technology, SPMVV, Tirupati-517502, Andhra Pradesh, India.
B. Mayuri
Department of Pharmaceutical Chemistry, Annamacharya College of Pharmacy,
Rajampet-516126, Kadapa, Andhra Pradesh, India.
View
Book :- https://stm.bookpi.org/TIPR-V11/article/view/3131
Monday 6 September 2021
Role of Pyridine Containing Azetidinone Derivatives as Privileged Scaffolds in Anti Tubercular Agents | Chapter 9 | Technological Innovation in Pharmaceutical Research Vol. 11
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment